In this new report, Mandala and Private Healthcare Australia (PHA) examine the affordability of specialist care in Australia. The analysis shows that specialist fees are increasing, intensifying cost-of-living pressures for consumers and further undermining the affordability of healthcare.
Policy & Research
High growth product groups on the Prescribed List
This report highlights areas of the Prostheses List where there was high growth between 2022-23 and 2023-24. Changes to MBS service levels are the most common reason for a Prescribed List product group to experience high growth, as expected.
Reducing out-of-pocket costs for healthcare consumers
A new report by Mandala examines the rising burden of out-of-pocket costs for Australians using the private health system. It outlines the drivers, policy options, and the potential cost of inaction.
Australia’s Surgical Surcharge: How Australians are paying too much for medical devices through the Prescribed List of Medical Devices
A new report by Mandala shows the damaging impact overpricing of generic medical devices has on Australia’s health system and private health insurance premiums.
There’s no place like home – reforming out-of-hospital care
A significant refocus of Australia’s health system on the provision of healthcare outside hospital settings will be critical to its long term sustainability, and ensuring it meets the demands of 21st century Australia, a landmark report has found.